Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEADY-PD: Isradipine CR in early Parkinson's disease
NCT00909545Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jul 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Isradipine in Parkinson's disease (PD), sponsored by Northwestern University. Started Jul 2009; status: completed.
02
Drugs
Isradipine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00909545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909545.